BYL719 (Alpelisib)
Important Notice: For research use only. We do not sell to patients.
Other Forms of BYL719 (Alpelisib)
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | BLY719 is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. | ||
---|---|---|---|
Targets |
|
Catalog Num | A11328 |
---|---|
Formula | C19H22F3N5O2S |
Molecular Weight | 441.5 |
CAS Number | 1217486-61-7 |
SMILES | CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F |
Synonyms | BYL-719 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 77 mg/mL (174.41 mM) | |
Water | Insoluble | ||
Ethanol | 2 mg/mL (4.53 mM) | ||
In vivo | 5%DMSO+40%PEG300+5%Tween80+50%ddH2O | 4.1 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.65 mL | 113.25 mL | 226.5 mL |
0.5 mM | 4.53 mL | 22.65 mL | 45.3 mL |
1 mM | 2.27 mL | 11.33 mL | 22.65 mL |
5 mM | 0.45 mL | 2.27 mL | 4.53 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2